348 |
Maulana A.M.; Kusmardi K.; Purwaningsih E.H.; Hestiantoro A.; Mahmud T.; Wibowo H.; Priosoeryanto B.P.; Rustamadji P.; Rusdi N.K. |
Maulana, Andi Muh (57290003500); Kusmardi, Kusmardi (56966625300); Purwaningsih, Erni Hernawati (57186723500); Hestiantoro, Andon (8743255100); Mahmud, Taifo (7004494540); Wibowo, Heri (57217690943); Priosoeryanto, Bambang Pontjo (6603282841); Rustamadji, Primariadewi (55321572200); Rusdi, Numlil Khaira (57211475250) |
Inhibitory Mechanisms of Soybean Extract on the Development of Breast Cancer Through Modulation of Cellular Immune Response |
Pharmacognosy Journal |
1 |
Doctoral Program in Biomedical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Department of Anatomy, Faculty of Medicine, Universitas Muhammadiyah Purwokerto, Central Java, Banyumas, Indonesia; Department of Pathological Anatomy, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Drug Development Research Center, Indonesian Medical Education and Research Institute, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Human Cancer Research Center, Indonesian Medical Education and Research Institute, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Department of Medical Pharmaceutical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Department of Pharmaceutical Sciences, Oregon State University, 203 Pharmacy Building, Corvallis, 97331, OR, United States; Department of Parasitology - Integrated Laboratory, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Division of Veterinary Pathology, School of Veterinary Medicine and Biomedical Sciences, IPB University, Bogor, Indonesia; Faculty of Pharmacy and Sciences, Universitas Muhammadiyah Prof. DR. Hamka, Jakarta, Indonesia |
Universitas Indonesia, UI, (NKB-421/ UN2.RST/HKP.05.00/2022) |
EManuscript Technologies |
Q3 |
|
|